International Vaccine Access Center
Featured

Preventing Cancer: The Far-Reaching Impact of Vaccines
For World Cancer Day, we highlight vaccines that have been shown to effectively protect against cancer-causing viruses, including human papillomavirus (HPV) and hepatitis B virus (HBV).

The Economic Impact of the Ongoing Measles Outbreak
Beyond the devastating health impacts, measles outbreaks can have significant financial implications. As the number of measles cases in the United States continues to grow, so too does the price tag associated with this outbreak.

RSV Vaccines Projected to Protect Infants and Seniors This Season
Based on the latest projections from the RSV Scenario Modeling Hub, between July 2024 and June 2025, interventions are expected to avert thousands of cases of severe disease that would require hospitalization.

Accelerating global access to life-saving vaccines.
We apply rigorous science to build knowledge and support for the value of vaccines.
IVAC's Work
The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.
Where We Work
IVAC works with governments and major research institutions in 38 countries. Learn more about us.

What We Do: Project Highlights
Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>
Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >
Stay Connected
Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.